Intrepid Family Office’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Intrepid Family Office's PFE Position: Q2 2025 in Review
Intrepid Family Office sold out of Pfizer (PFE) in Q2 2025, closing a stake of 65,000 shares — an estimated $1.65M sold.
Intrepid Family Office first reported a position in PFE in Q4 2021 and held it in 6 quarters. The position peaked at $2.95M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Intrepid Family Office reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Intrepid Family Office sold 65,000 Pfizer shares in Q2 2025, an estimated $1.65M.
- Intrepid Family Office first reported a position in Pfizer in Q4 2021 and held it in 6 quarters.
- Intrepid Family Office's Pfizer position peaked at $2.95M in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Intrepid Family Office's 13F filing for Q2 2025, filed 14 Aug 2025.